BioProcure
PrivateLast Round
Growth Equity
Oct 18, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioProcure is a biotechnology services company that provides outsourced procurement, accounts payable, and administrative support services for life science organizations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Supply Chain, Workflow Automation, Accounting & Expense
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioProcure Comparables
Compare BioProcure with similar companies based on industry and business-model similarity.
BioProcure Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
BioProcure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PNC Erieview Capital | Growth Equity |
| Primus Capital Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 64% MoM.
- Jun 19, 2026
Monthly visitors grew 216% MoM to 2.1K.
BioProcure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioProcure's valuation, stock price, and market status.
Is BioProcure a public or private company?
BioProcure is a private company.
What is the current stock price of BioProcure?
BioProcure is a private company, so its shares have no public market price. Caplight tracks BioProcure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioProcure worth (valuation)?
Valuation information for BioProcure is not publicly available.
Can I buy BioProcure stock?
BioProcure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioProcure's last funding round?
BioProcure's most recent funding round was Growth Equity on October 18, 2023.
Who are the main investors in BioProcure?
Key investors in BioProcure include Primus Capital Partners.
Will BioProcure IPO soon?
No public IPO plans have been announced for BioProcure.
How can I track BioProcure secondary market activity?
Caplight tracks bids, offers, and trades in BioProcure's shares on secondary markets.